Toggle Nav
Close
  • Menu
  • Setting

Anti-IL-23 Antibody (Mirikizumab)

Catalog No.
F1287
Anti-IL-23 Antibody (Mirikizumab)
Grouped product items
SizePriceStock Qty
100ug
$78.00
Ship with 3-5 days
1mg
$234.00
Ship with 3-5 days
5mg
$655.00
Ship with 3-5 days
50mg
$2,195.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin-23 (IL-23). Mirikizumab binds human and monkey IL-23 with high affinity, with Kd values of 21 pM and 55 pM, respectively. Mirikizumab modulates immune responses by inhibiting the binding of IL-23 to IL-23R and is expected to be used in the study of ulcerative colitis and Crohn's disease.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

1884201-71-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

LY 3074828

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q9NPF7

Reactivity

Human

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG4SP

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

IL-23

Note

Please avoid freeze-thaw cycles.